De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy

Kevin S. Sieja MD; Gregory T. Everson MD

首页> 外文期刊>Digestive Diseases and Sciences >De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy

【24h】

De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy

机译：从头开始对干扰素/利巴韦林疗法进行病毒学应答后5年的慢性丙型肝炎患者从头开始肝细胞癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Digestive Diseases and Sciences》 |2006年第3期|600-602|共3页
作者
Kevin S. Sieja MD; Gregory T. Everson MD;
展开▼
作者单位

Division of Gastroenterology and Hepatology University of Colorado Health Sciences Center Denver Colorado USA;

Division of Gastroenterology and Hepatology University of Colorado Health Sciences Center Denver Colorado USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
chronic hepatitis C; interferon; sustained responder; hepatocellular carcinoma;

机译：慢性丙型肝炎;干扰素;持续应答者;肝细胞癌;

相似文献

外文文献
中文文献
专利

1. De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy. [J] . Sieja KS, Everson GT Digestive Diseases and Sciences . 2006,第3期

机译：在对干扰素/利巴韦林治疗产生持续病毒学应答后的5年内，在患有慢性丙型肝炎的患者中从头发生了肝细胞癌。
2. De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy. [J] . Sieja KS, Everson GT Digestive Diseases and Sciences . 2006,第3期

机译：在对干扰素/利巴韦林治疗产生持续病毒学应答后的5年内，在患有慢性丙型肝炎的患者中从头发生了肝细胞癌。
3. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin. [J] . Perrella A, Sbreglia C, Atripaldi L, Scandinavian journal of gastroenterology. . 2010,第2期

机译：丙型肝炎病毒基因型1型慢性丙型肝炎患者接受聚乙二醇化干扰素α2a加利巴韦林治疗后，外周血单核细胞快速的病毒学应答会随丙型肝炎病毒特异性干扰素-γ产生的增加而产生持续的病毒学应答。
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. Patient Experience on Therapy for Hepatitis C Virus, The Impact of Successful Treatment on Liver Stiffness, and The Meaning of Sustained Virologic Response [D] . Nickerson, Jillian Elizabeth 2015

机译：乙型肝炎病毒治疗患者体验，成功治疗对肝硬化的影响，以及持续的病毒性反应的含义
6. Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy [O] . Tasuku Hara, Tomoya Ohara, Masashi Taniguchi, 2020

机译：慢性丙型肝炎患者肝细胞癌21岁以达到干扰素治疗的持续病毒学反应后的肝细胞癌
7. Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients 20 Years after Achieving a Sustained Virological Response with Interferon Therapy: A Report of Two Cases [O] . Go Igarashi, Tetsu Endo, Naoya Sawada, 2015

机译：慢性丙型肝炎患者肝细胞癌的发展20年后达到干扰素治疗的持续病毒学应答：两种情况的报告

De Novo Hepatocellular Carcinomain a Patient with Chronic Hepatitis C 5 Years After Sustained Virologic Response to Interferon/Ribavirin Therapy

著录项

相似文献

相关主题

期刊订阅